Cargando…

(18)F-Facbc in Prostate Cancer: A Systematic Review and Meta-Analysis

Trans-1-amino-3-(18)F-fluorocyclobutanecarboxylic-acid (anti-[(18)F]-FACBC) has been approved for the detection of prostate cancer (PCa) in patients with elevated prostate-specific-antigen following prior treatment. This review and meta-analysis aimed to investigate the diagnostic performance of (18...

Descripción completa

Detalles Bibliográficos
Autores principales:	Laudicella, Riccardo, Albano, Domenico, Alongi, Pierpaolo, Argiroffi, Giovanni, Bauckneht, Matteo, Baldari, Sergio, Bertagna, Francesco, Boero, Michele, De Vincentis, Giuseppe, Del Sole, Angelo, Rubini, Giuseppe, Fantechi, Lorenzo, Frantellizzi, Viviana, Ganduscio, Gloria, Guglielmo, Priscilla, Nappi, Anna Giulia, Evangelista, Laura
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6769578/ https://www.ncbi.nlm.nih.gov/pubmed/31514479 http://dx.doi.org/10.3390/cancers11091348

Ejemplares similares

Somatostatin Receptor PET/CT Imaging for the Detection and Staging of Pancreatic NET: A Systematic Review and Meta-Analysis
por: Bauckneht, Matteo, et al.
Publicado: (2020)

Theragnostic Use of Radiolabelled Dota-Peptides in Meningioma: From Clinical Demand to Future Applications
por: Laudicella, Riccardo, et al.
Publicado: (2019)

The Role of PET in Supratentorial and Infratentorial Pediatric Brain Tumors
por: Cistaro, Angelina, et al.
Publicado: (2021)

Impact of the COVID-19 pandemic in nuclear medicine departments: preliminary report of the first international survey
por: Annunziata, Salvatore, et al.
Publicado: (2020)

Clinical Applications of TSPO PET for Glioma Imaging: Current Evidence and Future Perspective—A Systematic Review
por: Filippi, Luca, et al.
Publicado: (2023)

The prognostic power of 18F-FDG PET/CT extends to estimating systemic treatment response duration in metastatic castration-resistant prostate cancer (mCRPC) patients
por: Bauckneht, Matteo, et al.
Publicado: (2021)

Head-to-Head Comparison between FDG and (11)C-Methionine in Multiple Myeloma: A Systematic Review
por: Filippi, Luca, et al.
Publicado: (2023)

Surveys on COVID-19 in nuclear medicine: what happened and what we learned
por: Annunziata, Salvatore, et al.
Publicado: (2020)

111In-Octreoscan SPECT/CT hybrid imaging and 68Ga-DOTANOC PET/CT in neuroendocrine adenoma of the middle ear (NAME)
por: Pontico, Mariano, et al.
Publicado: (2020)

Unexpected Detection of Abscessualized Lung Carcinoma on Tc-99m-HMPAO-labeled Leukocytes Scintigraphy Misdiagnosed on Chest Computed Tomography
por: Cosma, Laura, et al.
Publicado: (2021)

The Role of 18F-FDG PET/CT in Staging and Prognostication of Mantle Cell Lymphoma: An Italian Multicentric Study
por: Albano, Domenico, et al.
Publicado: (2019)

Initial evaluation of [(18)F]-FACBC for PET imaging of multiple myeloma
por: Morath, Volker, et al.
Publicado: (2022)

Diagnostic Value of (18)F-FACBC PET/MRI in Brain Metastases
por: Øen, Silje Kjærnes, et al.
Publicado: (2022)

Analysis of Unusual Adverse Effects After Radium-223 Dichloride  Administration
por: Frantellizzi, Viviana, et al.
Publicado: (2020)

Radio-Guided Lung Surgery: A Feasible Approach for a Cancer Precision Medicine
por: Conte, Miriam, et al.
Publicado: (2023)

Personalized Dosimetry in the Context of Radioiodine Therapy for Differentiated Thyroid Cancer
por: Pacilio, Massimiliano, et al.
Publicado: (2022)

PET Radiomics and Response to Immunotherapy in Lung Cancer: A Systematic Review of the Literature
por: Evangelista, Laura, et al.
Publicado: (2023)

Clinical Applications of Immuno-PET in Lymphoma: A Systematic Review
por: Triumbari, Elizabeth Katherine Anna, et al.
Publicado: (2022)

DNA Damage Repair Defects and Targeted Radionuclide Therapies for Prostate Cancer: Does Mutation Really Matter? A Systematic Review
por: Filippi, Luca, et al.
Publicado: (2022)

Clinical Impact of (18)F-FDG PET/CT in the Diagnostic Workup of Pancreatic Ductal Adenocarcinoma: A Systematic Review
por: Arnone, Annachiara, et al.
Publicado: (2020)

(18)F-Fluciclovine ((18)F-FACBC) PET imaging of recurrent brain tumors
por: Michaud, Laure, et al.
Publicado: (2019)

The DASciS Software for BSI Calculation as a Valuable Prognostic Tool in mCRPC Treated with 223RaCl2: A Multicenter Italian Study
por: De Feo, Maria Silvia, et al.
Publicado: (2023)

Role of Exendin-4 Functional Imaging in Diagnosis of Insulinoma: A Systematic Review
por: Sidrak, Marko Magdi Abdou, et al.
Publicado: (2023)

(18)F-FACBC PET/MRI in the evaluation of human brain metastases: a case report
por: Johannessen, Knut, et al.
Publicado: (2021)

Subcutaneous Uptake on [18F]Florbetaben PET/CT: a Case Report of Possible Amyloid-Beta Immune-Reactivity After COVID-19 Vaccination
por: Laudicella, Riccardo, et al.
Publicado: (2021)

Radium-223 Treatment in mCRPC Patient with Polycythemia Vera
por: de Angelis, Cristina, et al.
Publicado: (2021)

Prediction of prostate cancer aggressiveness using (18)F-Fluciclovine (FACBC) PET and multisequence multiparametric MRI
por: Movahedi, Parisa, et al.
Publicado: (2020)

Diagnostic Performance of PET/CT Using 18F-FACBC in Prostate Cancer: A Meta-Analysis
por: Bin, Xu, et al.
Publicado: (2020)

Combined forced diuresis and late acquisition on [(68)Ga]Ga-PSMA-11 PET/CT for biochemical recurrent prostate cancer: a clinical practice-oriented study
por: Bauckneht, Matteo, et al.
Publicado: (2023)

Manejo de pacientes con CPRCm tratados con dicloruro de radio-223 en el escenario del brote de COVID-19
por: Frantellizzi, V., et al.
Publicado: (2020)

Manejo de pacientes con CPRCm tratados con dicloruro de radio-223 en el escenario del brote de COVID-19
por: Frantellizzi, V., et al.
Publicado: (2020)

PSMA and Choline PET for the Assessment of Response to Therapy and Survival Outcomes in Prostate Cancer Patients: A Systematic Review from the Literature
por: Alongi, Pierpaolo, et al.
Publicado: (2022)

The Utility of Conventional Amino Acid PET Radiotracers in the Evaluation of Glioma Recurrence also in Comparison with MRI
por: Santo, Giulia, et al.
Publicado: (2022)

Prognostic Value of the BIO-Ra Score in Metastatic Castration-Resistant Prostate Cancer Patients Treated with Radium-223 after the European Medicines Agency Restricted Use: Secondary Investigations of the Multicentric BIO-Ra Study
por: Bauckneht, Matteo, et al.
Publicado: (2022)

Assessment of Amino Acid/Drug Transporters for Renal Transport of [(18)F]Fluciclovine (anti-[(18)F]FACBC) in Vitro
por: Ono, Masahiro, et al.
Publicado: (2016)

Scintigraphic Load of Bone Disease Evaluated by DASciS Software as a Survival Predictor in Metastatic Castration-resistant Prostate Cancer Patients Candidates to 223RaCl Treatment
por: Frantellizzi, Viviana, et al.
Publicado: (2019)

Medication and ECG Patterns That May Hinder SPECT Myocardial Perfusion Scans
por: Sidrak, Marko Magdi Abdou, et al.
Publicado: (2023)

Validation of the 3-variable prognostic score (3-PS) in mCRPC patients treated with (223)Radium-dichloride: a national multicenter study
por: Frantellizzi, Viviana, et al.
Publicado: (2020)

PET Criteria by Cancer Type from Imaging Interpretation to Treatment Response Assessment: Beyond FDG PET Score
por: Dondi, Francesco, et al.
Publicado: (2023)

The prognostic power of inflammatory indices and clinical factors in metastatic castration-resistant prostate cancer patients treated with radium-223 (BIO-Ra study)
por: Bauckneht, Matteo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jfdm5smc1dom1u66fov5vd628h